Newsfeeds - Spark Newswire

1 minute read

NovoCure Q3 EPS $(0.13) Misses $(0.07) Estimate, Sales $133.60M Miss $141.76M Estimate

Today, 9:49 PM

NovoCure (NASDAQ:NVCR) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.07) by 85.71 percent. This is a 244.44 percent decrease over earnings of $0.09 per share from the

NVCR

19 minute read

Earnings Scheduled For October 28, 2021

By Benzinga Insights

Today, 9:49 PM

Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million.

AAPL

4 minute read

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More

By Shanthi Rexaline

Today, 9:49 PM

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength.

ABBV

3 minute read

Events
News

Novocure Announces 15 Presentations At The American Society For Radiation Oncology 2021 Annual Meeting

By Benzinga Newsdesk

Today, 9:49 PM

Novocure (NASDAQ:NVCR) today announced 15 presentations on Tumor Treating Fields (TTFields) will be featured at the American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting from Oct. 24 to Oct. 27 in Chicago.

NVCR

1 minute read

Cramer Likes Ford, But Suggests Waiting For Dips To Buy These Stocks

By Craig Jones

Today, 9:49 PM

On Friday's "Mad Money Lightning Round," Jim Cramer said that he had liked Logitech International SA (NASDAQ: LOGI) since the $30s.

5 minute read

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer’s Sleep Disorder Drug Filing Accepted For Review, Voyager’s Licensing Options Deal

By Shanthi Rexaline

Today, 9:49 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5)

ABEO

1 minute read

Novocure To Test Its Tumor Treating Fields With Roche’s Tecentriq In Pancreatic Cancer

By Vandana Singh

Today, 9:49 PM

Novocure Ltd (NASDAQ:NVCR) has entered into a clinical trial collaboration agreement with Roche Holdings AG (OTC:RHHBY) to develop Tumor Treating Fields (TTFields) together…

NVCR

6 minute read

The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen’s Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout

By Shanthi Rexaline

Today, 9:49 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13)

ABT

1 minute read

Cramer Advises Viewers On Palantir, SoFi And More

By Craig Jones

Today, 9:49 PM

On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't understand why is MKS Instruments, Inc. (NASDAQ: MKSI) trading so cheap. He would be a buyer.

AUPH

1 minute read

Mizuho Maintains Neutral on NovoCure, Lowers Price Target to $200

By Benzinga Newsdesk

Today, 9:49 PM

Mizuho analyst Difei Yang maintains NovoCure (NASDAQ:NVCR) with a Neutral and lowers the price target from $229 to $200.

NVCR